K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis

Kyoung Hwa Koo, Woo Jeong Jeong, Yong Hee Cho, Jong Chan Park, Do Sik Min, Kang Yell Choi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Estrogens are considered as a major risk factor of endometrial cancer. In this study, we identified a mechanism of tumorigenesis in which K-Ras protein is stabilized via estrogen signaling through the ER-a36 receptor. PKCδ was shown to stabilize K-Ras specifically via estrogen signaling. Estrogens stabilize K-Ras via inhibition of polyubiquitylation-dependent proteasomal degradation. Estrogen-induced cellular transformation was abolished by either K-Ras or PKCδ knockdown. The role of PKCδ in estrogen-induced tumorigenesis was confirmed in a mouse xenograft model by reduction of tumors after treatment with rottlerin, a PKCδ inhibitor. Finally, levels of PKCδ correlated with that of Ras in human endometrial tumor tissues. Stabilization of K-Ras by estrogen signaling involving PKCδ up-regulation provides a potential therapeutic approach for treatment of endometrial cancer.

Original languageEnglish
Pages (from-to)21328-21340
Number of pages13
JournalOncotarget
Volume6
Issue number25
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Estrogens
Carcinogenesis
Endometrial Neoplasms
ras Proteins
Heterografts
Neoplasms
Up-Regulation

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Koo, Kyoung Hwa ; Jeong, Woo Jeong ; Cho, Yong Hee ; Park, Jong Chan ; Min, Do Sik ; Choi, Kang Yell. / K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis. In: Oncotarget. 2015 ; Vol. 6, No. 25. pp. 21328-21340.
@article{48ab76217fa84d19ad189509bd7c41b6,
title = "K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis",
abstract = "Estrogens are considered as a major risk factor of endometrial cancer. In this study, we identified a mechanism of tumorigenesis in which K-Ras protein is stabilized via estrogen signaling through the ER-a36 receptor. PKCδ was shown to stabilize K-Ras specifically via estrogen signaling. Estrogens stabilize K-Ras via inhibition of polyubiquitylation-dependent proteasomal degradation. Estrogen-induced cellular transformation was abolished by either K-Ras or PKCδ knockdown. The role of PKCδ in estrogen-induced tumorigenesis was confirmed in a mouse xenograft model by reduction of tumors after treatment with rottlerin, a PKCδ inhibitor. Finally, levels of PKCδ correlated with that of Ras in human endometrial tumor tissues. Stabilization of K-Ras by estrogen signaling involving PKCδ up-regulation provides a potential therapeutic approach for treatment of endometrial cancer.",
author = "Koo, {Kyoung Hwa} and Jeong, {Woo Jeong} and Cho, {Yong Hee} and Park, {Jong Chan} and Min, {Do Sik} and Choi, {Kang Yell}",
year = "2015",
month = "1",
day = "1",
doi = "10.18632/oncotarget.4049",
language = "English",
volume = "6",
pages = "21328--21340",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "25",

}

K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis. / Koo, Kyoung Hwa; Jeong, Woo Jeong; Cho, Yong Hee; Park, Jong Chan; Min, Do Sik; Choi, Kang Yell.

In: Oncotarget, Vol. 6, No. 25, 01.01.2015, p. 21328-21340.

Research output: Contribution to journalArticle

TY - JOUR

T1 - K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis

AU - Koo, Kyoung Hwa

AU - Jeong, Woo Jeong

AU - Cho, Yong Hee

AU - Park, Jong Chan

AU - Min, Do Sik

AU - Choi, Kang Yell

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Estrogens are considered as a major risk factor of endometrial cancer. In this study, we identified a mechanism of tumorigenesis in which K-Ras protein is stabilized via estrogen signaling through the ER-a36 receptor. PKCδ was shown to stabilize K-Ras specifically via estrogen signaling. Estrogens stabilize K-Ras via inhibition of polyubiquitylation-dependent proteasomal degradation. Estrogen-induced cellular transformation was abolished by either K-Ras or PKCδ knockdown. The role of PKCδ in estrogen-induced tumorigenesis was confirmed in a mouse xenograft model by reduction of tumors after treatment with rottlerin, a PKCδ inhibitor. Finally, levels of PKCδ correlated with that of Ras in human endometrial tumor tissues. Stabilization of K-Ras by estrogen signaling involving PKCδ up-regulation provides a potential therapeutic approach for treatment of endometrial cancer.

AB - Estrogens are considered as a major risk factor of endometrial cancer. In this study, we identified a mechanism of tumorigenesis in which K-Ras protein is stabilized via estrogen signaling through the ER-a36 receptor. PKCδ was shown to stabilize K-Ras specifically via estrogen signaling. Estrogens stabilize K-Ras via inhibition of polyubiquitylation-dependent proteasomal degradation. Estrogen-induced cellular transformation was abolished by either K-Ras or PKCδ knockdown. The role of PKCδ in estrogen-induced tumorigenesis was confirmed in a mouse xenograft model by reduction of tumors after treatment with rottlerin, a PKCδ inhibitor. Finally, levels of PKCδ correlated with that of Ras in human endometrial tumor tissues. Stabilization of K-Ras by estrogen signaling involving PKCδ up-regulation provides a potential therapeutic approach for treatment of endometrial cancer.

UR - http://www.scopus.com/inward/record.url?scp=84940728980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940728980&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.4049

DO - 10.18632/oncotarget.4049

M3 - Article

C2 - 26015399

AN - SCOPUS:84940728980

VL - 6

SP - 21328

EP - 21340

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 25

ER -